CGTXCognition Therapeutics Inc
Earnings
When Cognition Therapeutics Inc reports, what it reported each quarter, and how the stock took the results.
27 quarters. Mar 31, 2020 to Sep 30, 2026. mixed units.
Next results · Q4 2026Projected
Mar 25, before the open
Thu, Mar 25, 2027in 128 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Mar 17 – Apr 2
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- —
- Net income
- -$3.34M
- Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m
Latest results
- Revenue
- —
- —
- Net income
- -$4.15M
- N/M
- EPS
- -$0.04
- N/M
- Revenue
- —
- —
- Net income
- -$3.93M
- N/M
- EPS
- -$0.04
- N/M
- Revenue
- —
- —
- Net income
- -$4.57M
- N/M
- EPS
- -$0.05
- N/M
- Revenue
- —
- —
- Net income
- -$3.34M
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Nov 5, 2026 · pre-market | Nov 5, 2026 | 36 d | 10-Q | — | — | -$0.04 | 7.0% | |
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · after-hours | Aug 7, 2026 | 38 d | 10-Q | — | — | -$0.04 | 4.4% | |
| Q1 2026 | Mar 31, 2026 | May 7, 2026 · after-hours | May 8, 2026 | 38 d | 10-Q | — | — | -$0.05 | +5.2% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Mar 26, 2026 · pre-market | Mar 26, 2026 | 85 d | 10-K | — | — | — | 3.2% | |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 · pre-market | Nov 6, 2025 | 37 d | 10-Q | — | — | -$0.06 | 2.4% | |
| Q2 2025 | Jun 30, 2025 | Aug 7, 2025 · after-hours | Aug 7, 2025 | 38 d | 10-Q | — | — | -$0.11 | +10.7% | |
| Q1 2025 | Mar 31, 2025 | May 7, 2025 · pre-market | May 7, 2025 | 37 d | 10-Q | — | — | -$0.14 | 15.6% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Mar 20, 2025 · pre-market | Mar 20, 2025 | 79 d | 10-K | — | — | — | 4.6% | |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 · pre-market | Nov 13, 2024 | 44 d | 10-Q | — | — | -$0.25 | 10.3% | |
| Q2 2024 | Jun 30, 2024 | Aug 8, 2024 · pre-market | Aug 8, 2024 | 39 d | 10-Q | — | — | -$0.18 | — | |
| Q1 2024 | Mar 31, 2024 | May 7, 2024 · pre-market | May 7, 2024 | 37 d | 10-Q | — | — | -$0.27 | — | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Mar 26, 2024 · pre-market | Mar 26, 2024 | 86 d | 10-K | — | — | — | 0.0% | |
| Q3 2023 | Sep 30, 2023 | Nov 2, 2023 · pre-market | Nov 2, 2023 | 33 d | 10-Q | — | — | -$0.22 | — | |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 · pre-market | Aug 8, 2023 | 39 d | 10-Q | — | — | -$0.16 | — | |
| Q1 2023 | Mar 31, 2023 | May 4, 2023 · after-hours | May 4, 2023 | 34 d | 10-Q | — | — | -$0.21 | — | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Mar 23, 2023 · pre-market | Mar 23, 2023 | 82 d | 10-K | — | — | — | +3.4% | |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 · pre-market | Nov 14, 2022 | 45 d | 10-Q | — | — | -$0.29 | 6.1% | |
| Q2 2022 | Jun 30, 2022 | Aug 9, 2022 · pre-market | Aug 9, 2022 | 40 d | 10-Q | — | — | -$0.25 | 4.7% | |
| Q1 2022 | Mar 31, 2022 | May 11, 2022 · pre-market | May 11, 2022 | 41 d | 10-Q | — | — | -$0.17 | 7.0% | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | Mar 30, 2022 · pre-market | Mar 30, 2022 | 89 d | 10-K | — | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 17, 2021 | 48 d | 10-Q | — | — | -$8.12 | — | |
| Q2 2021 | Jun 30, 2021 | — | — | — | — | — | — | -$4.77 | — | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | — | — | -$1.64 | — | |
| FY 2020 | ||||||||||
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | — | — | -$5.31 | — | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | — | — | — | — | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | — | — | — | — | |
Earlier years, FY 2020 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Cognition Therapeutics Inc · CIK 1455365 · Engraved from SEC EDGAR